CHARLOTTE LANPHEAR: Open Payments
NPI 1497220826 · LUTHERVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,282 in 118 payments from 19 companies in 2025. Trend: 2023 $1,501 · 2024 $1,908 · 2025 $10,282
Consulting: $6,900Food & beverage: $3,183Education: $198
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 4 | $6,900 |
| Janssen Biotech, Inc. | 12 | $517 |
| ABBVIE INC. | 21 | $507 |
| E.R. Squibb & Sons, L.L.C. | 12 | $330 |
| GENZYME CORPORATION | 9 | $319 |
| Regeneron Healthcare Solutions, Inc. | 8 | $299 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $249 |
| Novartis Pharmaceuticals Corporation | 5 | $245 |
| Lilly USA, LLC | 10 | $184 |
| UCB, Inc. | 7 | $183 |
Products named: EBGLYSS, DUPIXENT, TREMFYA, Sotyktu, RINVOQ, SKYRIZI, Bimzelx, TALTZ.
Industry payments across MD — which companies pay providers there.
